Le Lézard
Classified in: Health
Subject: IMA

One-stop Solution for Wound Healing


TAICEND - your expert partner for wound healing solution

ATLANTA, Oct. 18, 2022 /PRNewswire/ -- TAICEND TECHNOLOGY intends to target its marketing strategy primarily on the US medical market. We will participate in the MedTrade East International Medical Home Care and Rehabilitation Exhibition for the first time on October 24-26 this year. It is the only largest and most popular medical exhibition in the east coast of the United States. For large manufacturers, the exhibition is a great opportunity to find potential customers and rebuild existing client relations. The MedTrade East exhibition focuses on the latest technologies from all over the world and attracts many buyers, in which a long-term cooperative relationship with buyers can be established.

A new generation of material technology that redefines the old concept of wound care

TAICEND TECHNOLOGY will display a series of wound healing products, not only presenting the characteristics of a single product, but also bringing the concept of treatment into the field of wound healing. The TAICEND TECHNOLOGY R&D team has developed a new generation of material technology and redefined the former concept in the field of wound care. This has improved product efficacy and cut the amount of time required for chronic wound healing by nearly half. The company also provides suitable solutions and products tailored for each customer. In addition to reducing the care and economic burden on family members and patients, it also makes it easier for medical staff to handle the wound well, and is a more effective solution for wound healing.

Master the properties of the material to overcome skin damage

TAICEND TECHNOLOGY also solves material allergy issues that has plagued the medical field. In addition to discussing more effective treatment methods with medical staff, we hope to solve issues that inconvenience patients. One of these issues is the often cited "allergy" problem. The use of wound dressings can cause skin allergies surrounding the wound, and in some cases cause MARSI (Medical Adhesives Related Skin Injuries). To combat this, we use viscose technology and volatilize the organic solvent more completely in the process, reduce the monomer residue of the material, reduce the possibility of sensitization, overcome the damage to the patient's skin, and reduce the hassle of medical staff or patients when they removing dressings.

Fulfill unmet needs in wound healing and find the niche

The wound dressing market is considered a "red ocean" in marketing terms. TAICEND TECHNOLOGY has entered the market with different concepts, using the most advanced material technology to meet the unmet needs of the wound care market. We use selected raw materials and R&D technology to best meet the needs of the public, improving the overall care environment. We also select particular manufacturing processes, allowing patients to use each product of TAICEND TECHNOLOGY for faster wound healing. Thanks to our products, the skin around the wound is free from burden and allergies. TAICEND TECHNOLOGY is committed to its problem-solving based approach and high-principled process.

Please visit us at the TAICEND TECHNOLOGY booth.

Exhibition time: October 24-26, 2022

Venue: Georgia World Congress Center

Exhibition address: 285 ANDREW YOUNG INTERNATIONAL BLVD., NE ATLANTA, GEORGIA 30313-1591

Media Contact:

JouPei Wu
0981118607
[email protected] 

SOURCE TAICEND TECHNOLOGY


These press releases may also interest you

at 21:27
Today, The Kids Mental Health Foundation (KMHF) hosted a panel alongside the Mental Health Storytelling, which is housed at the USC Annenberg Inclusion Initiative, in New York City. The...

at 20:40
The Board of Juno Pharmaceuticals Corporation is excited to announce the appointment of Jean-Guy Goulet as Chief Executive Officer (CEO). An executive with over 35 years of experience in the pharmaceutical industry, overseeing activities in Canada...

at 20:37
Mexico's pharmaceutical and personal care industry is undergoing significant changes with the strategic moves announced by Genomma Lab International, S.A.B. de C.V. (B.M.V.: LABB) regarding its agreement to redeem capital in Marzam. The...

at 20:35
Insert as subheadline: NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES The updated release reads: ZYUS LIFE SCIENCES CORPORATION TO PRESENT AT SIDOTI VIRTUAL INVESTOR CONFERENCE MAY 8-9 NOT FOR...

at 20:15
Voomtm Medical Devices, Inc. ("Voom"), a human-forward medical device company leading the transformation of surgical bunion correction, has pioneered a significant advancement in the standard of care in surgical bunion repair. The company is pleased...

at 20:10
Fresh off the revamped formula release of their patented creatine infused ready to drink recovery beverage, FITAID delivers a unique product drop strategy, putting customers in control of their permanent flavor collection. With the record...



News published on and distributed by: